Mutational analysis of Phe160 within the "palm" subdomain of human immunodeficiency virus type 1 reverse transcriptase

被引:23
|
作者
Gutiérrez-Rivas, M
Ibáñez, A
Martínez, MA
Domingo, E
Menéndez-Arias, L
机构
[1] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
[2] Hosp Badalona Germans Trias & Pujol, Fdn Irsi Caixa, Lab Retrovirol, Barcelona, Spain
关键词
reverse transcriptase; HIV-1; polymerase; AIDS; nucleotides;
D O I
10.1006/jmbi.1999.2880
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The highly conserved Phe160 residue is located in the "palm" subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), and makes contact with Tyr115, a residue which is involved in deoxynucleoside triphosphate (dNTP) binding and fidelity of DNA synthesis. Five mutant RTs having Tyr, Trp, lie, Ala or Gin instead of Phe160 were obtained by site-directed mutagenesis. F160Y and F160W retained substantial DNA polymerase activity, whereas the catalytic efficiency of nucleotide incorporation of mutants F160I, F160A and F160Q was less than 10% that of the wild-type RT, using poly(rA).oligo(dT)(20) as the template-primer. The low catalytic efficiency of mutants F160I, F160A and F160Q was due to their lower affinity for the dNTP substrate. F160Y displayed similar kinetic parameters as the wild-type RT in nucleotide insertion assays carried out with heteropolymeric DNA/DNA template-primers. However, nucleotide affinity was two- to sixfold reduced in the case of mutant F160W. Fidelity assays revealed similar misinsertion and mispair extension ratios for the three enzymes, although F160W showed a slightly higher accuracy of DNA synthesis, particularly in the presence of high concentrations of dNTP. When introduced in an infectious proviral clone, mutations F160I, F160A and F160Q rendered non-viable virus. The importance of Phe160 for polymerase function and viral replication could be mediated by its interaction with Tyr115, as suggested by the analysis of the available crystal structures of HIV-1 RT. (C) 1999 Academic Press.
引用
收藏
页码:615 / 625
页数:11
相关论文
共 50 条
  • [31] Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate
    QuinonesMateu, ME
    Soriano, V
    Domingo, E
    MenendezArias, L
    VIROLOGY, 1997, 236 (02) : 364 - 373
  • [32] Inhibition of human immunodeficiency virus type 1 reverse transcriptase by degradation products of ceftazidime
    Baertschi, SW
    Cantrell, AS
    Kuhfeld, MT
    Lorenz, LJ
    Boyd, DB
    Jaskunas, SR
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (04): : 353 - 362
  • [33] Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats
    Chang, M
    Sood, VK
    Wilson, GJ
    Kloosterman, DA
    Sanders, PE
    Hauer, MJ
    Fagerness, PE
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (02) : 228 - 242
  • [34] Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase
    Isaguliants, MG
    Pokrovskaya, K
    Kashuba, VI
    Pokholok, D
    Hinkula, J
    Wahren, B
    Kochetkov, SN
    FEBS LETTERS, 1999, 447 (2-3) : 232 - 236
  • [35] Effect of manuka honey on human immunodeficiency virus type 1 reverse transcriptase activity
    Obossou, Etienne Kochole
    Shikamoto, Yasuo
    Hoshino, Yuki
    Kohno, Hayato
    Ishibasi, Yukiko
    Kozasa, Tohru
    Taguchi, Maho
    Sakakibara, Iwao
    Tonooka, Keiko
    Shinozuka, Tatsuo
    Mori, Kazuya
    NATURAL PRODUCT RESEARCH, 2022, 36 (06) : 1552 - 1557
  • [36] KINETIC AND MUTATIONAL ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE INHIBITION BY INOPHYLLUMS, A NOVEL CLASS OF NONNUCLEOSIDE INHIBITORS
    TAYLOR, PB
    CULP, JS
    DEBOUCK, C
    JOHNSON, RK
    PATIL, AD
    WOOLF, DJ
    BROOKS, I
    HERTZBERG, RP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (09) : 6325 - 6331
  • [37] Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
    Hachiya, Atsuko
    Kodama, Eiichi N.
    Sarafianos, Stefan G.
    Schuckmann, Matthew M.
    Sakagami, Yasuko
    Matsuoka, Masao
    Takiguchi, Masafumi
    Gatanaga, Hiroyuki
    Oka, Shinichi
    JOURNAL OF VIROLOGY, 2008, 82 (07) : 3261 - 3270
  • [38] Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and moloney murine leukemia virus reverse transcriptase
    Gao, HQ
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (05) : 1097 - 1113
  • [39] Inhibition of Foamy Virus Reverse Transcriptase by Human Immunodeficiency Virus Type 1 RNase H Inhibitors
    Corona, Angela
    Schneider, Anna
    Schweimer, Kristian
    Roesch, Paul
    Woehrl, Birgitta M.
    Tramontano, Enzo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4086 - 4093
  • [40] Mutational analysis of the human immunodeficiency virus type 1 Vif protein
    Simon, JHM
    Sheehy, AM
    Carpenter, EA
    Fouchier, RAM
    Malim, MH
    JOURNAL OF VIROLOGY, 1999, 73 (04) : 2675 - 2681